MARIA ISABEL
CADAVID TORRES
Investigadora en el periodo 1987-2022
![Foto de MARIA ISABEL](/img/uploaded/F65F98BBEDA890AE8FA8D66015B7C6EC.png)
![Foto de University of Bari Aldo Moro](/img/noimage_org.png)
University of Bari Aldo Moro
Bari, ItaliaPublicaciones en colaboración con investigadores/as de University of Bari Aldo Moro (7)
2013
2008
-
1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor
Bioorganic and Medicinal Chemistry, Vol. 16, Núm. 6, pp. 2852-2869
-
Corrigendum to "1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor" [Bioorg. Med. Chem. 16 (2008) 2852-2869] (DOI:10.1016/j.bmc.2008.01.002)
Bioorganic and Medicinal Chemistry
2006
-
Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor
Journal of Medicinal Chemistry, Vol. 49, Núm. 1, pp. 282-299
2004
-
8-Substituted-9-deazaxanthines as adenosine receptor ligands: Design, synthesis and structure-affinity relationships at A 2B
European Journal of Medicinal Chemistry, Vol. 39, Núm. 10, pp. 879-887
2002
-
New serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptor antagonists: Synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones
Journal of Medicinal Chemistry, Vol. 45, Núm. 1, pp. 54-71
1999
-
Conformationally constrained butyrophenones with mixed dopaminergic (D2) and serotoninergic (5-HT2(A), 5-HT2(C)) affinities: Synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and - thienocycloalkanones as putative atypical antipsychotics
Journal of Medicinal Chemistry, Vol. 42, Núm. 15, pp. 2774-2797